... Adding apalutamide (Erleada) to androgen deprivation therapy (ADT) before and after prostate cancer surgery helped people with high-risk localized prostate cancer live longer without the cancer metastasizing (spreading) or recurring (coming back), according to results from the phase 3 PROTEUS trial.People who received apalutamide plus ADT had a 20 percent ...
New Combo Delays Prostate Cancer Spread After Surgery
... Adding apalutamide (Erleada) to androgen deprivation therapy (ADT) before and after prostate cancer surgery helped people with high-risk localized prostate cancer live longer without the cancer metastasizing (spreading) or recurring (coming back), according to results from the phase 3 PROTEUS trial.People who received apalutamide plus ADT had a 20 percent ...
... Examples include: Apalutamide (Erleada) Bicalutamide (Casodex) Darolutamide (Nubeqa) Enzalutamide (Xtandi) Flutamide Nilutamide (Nilandron) 4. Targeted TherapyTargeted therapy uses drugs that attack specific changes in cancer cells that aren’t found in healthy tissue. ...